1. Intraventricular clonidine and BAY 1470, administered in small doses to conscious renal hypertensive cats, produced a fall in mean blood pressure lasting for a period of 3 h. This fall in blood pressure was accompanied by a marked bradycardia.
Introduction
Clonidine and BAY 1470 are potent anti-hypertensive agents which act on central bulbar sympathetic centres leading to a reduction in peripheral sympathetic tone (Kobinger & Walland, 1967; Heise, Kroneberg & Schlossmann, 1971) . The hypotensive action of clonidine is thought to be mediated via central a-adrenoreceptors since piperoxan, yohimbine and intraventricular phentolamine antagonize the actions of clonidine (Schmitt, Schmitt & FCnard, 1971 ,1973 Bucher, Buckingham, Finch & Moore, 1973; Finch, 1974) . However, Eome investigators support the hypothesis of a pre-synaptic site of action (Starke & Altmann, 1973) , since the hypotensive responses to clonidine are prevented by pretreatment with desmethylimipramine or by intraventricular 6-hydroxydopamine (Reid, Brait & Dollery, 1973; Dollery & Reid, 1973) .
The present studies in conscious hypertensive cats and rats support the hypothesis of a central Nadrenoreceptor-stimulating mechanism for clonidine independent of an intact central adrenergic uptake mechanism.
Materials and methods
Cats were made hypertensive by wrapping one kidney with cellophan and contralateral nephrectomy under pentobarbitone anaesthesia. Three to 6 weeks later a catheter was passed down the carotid and the tiD located in the thoracic aorta. A one-way valve attached to the catheter was tied at the back of the neck, by the method described by Day & Whiting Finch (1972) . Lateral brain ventricular cannulae were also cemented into place by a modification of the method of Hayden, Johnson & Maickel (1966) . For recordings cats were starved overnight since it was found that clonidine and BAY 1470 produced emesis (see the Results section). Blood pressures were recorded in groups of four animals continually with a Statham pressure transducer, and heart rate was counted directly from the pulse trace by increasing the chart speed of the polygraph.
Rats were made hypertensive by unilateral nephrectomy, subcutaneous implantation of deoxycorticosterone acetate (50 nig) and replacing the drinking water with 154 mmol/l sodium chloride (saline). Blood pressure was recorded directly by a cannula inserted into the abdominal aorta. Groups of eight or more animals were used for each recording.
The following drugs were made up in normal saline immediately before administration : BAY 1470, 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazin (Bayer AG), clonidine HCI (Boehringer Ingelheim), desmethylimipramine (Ciba-Geigy), haloperidol (Janssen), 6-hydroxydopamine (F. Hoffmann-La Roche, Basle), 5,6-dihydroxytryptamine creatinine sulphate (F. Hoffmann-La Roche), phentolamine (Regitine, Ciba-Geigy), piperoxan, tolazoline (Priscol, Ciba-Geigy). 5,6-Dihydroxytryptamine and 6-hydroxydopamine were dissolved in 0.1 mg/ml ascorbic acid and nitrogenbubbled 0.01 mol/l HCI respectively.
Results
In conscious renal hypertensive cats, intraventricular clonidine (I 8-1 12 nmol) produced a dose-dependent fall in blood pressure which was also accompanied by a marked bradycardia ( with either desmethylimipramine (3.3 pmol/kg, intraperitoneally, or 1.7 pmol, intraventricularly) or haloperidol (2.6 pmolikg, intraperitoneally) did not modify the responses to intraventricular clonidine (75 nmol). In the animals pretreated with desmethylimipramine (3.3 pmol/kg, intraperitoneally) the pressor responses to intravenous noradrenaline were markedly potentiated and treatment with haloperidol produced catalepsy. The emesis observed immediately after intraventricular clonidine was still seen in animals pretreated with desmethylimipramine, haloperidol and the centrally administered a-adrenoreceptor blocking agents.
In conscious experimental hypertensive rats clonidine (0.6 pmolikg, intraperitoneally) produced a fall in blood pressure (mean 60 mmHg), which was accompanied by a marked bradycardia (100 beatsimin). Intraventricular phentolamine (6 pmol) administered 30 rnin beforehand completely abolished the cardiovascular response to clonidine (0.6 prnolikg, intraperitoneally). Similar results were obtained with peripheral administration of large doses of piperoxan (30 pmol/kg, intravenously). Rats pretreated with 6-hydroxydopamine (three doses of 1 pmol intraventricularly) or 5,6-dihydroxytryptamine (0.1 pmol) still exhibited hypotensive responses to clonidine (0.6 pmol/kg, intraperitoneally).
Discussion
In conscious experimental hypertensive cats, small doses of clonidine, given intraventricularly, produced a marked fall in blood pressure, which was accompanied by a bradycardia. Similar findings have been reported with peripheral administration of clonidine in several species (Schmitt et al., 1971 ; Dollery & Reid, 1973; Haeusler, 1973) . The antagonism of the hypotensive effect of clonidine by centrally acting a-adrenoreceptor blocking agents in conscious cats and rats confirms other studies in anaesthetized cats (Haeusler, 1973; Schmitt et al., 1973) .
The cardiovascular responses induced by intraventricular clonidine were not modified by centrally or peripherally administered desmethylimipramine, which contrasts with observations in conscious rabbits and anaesthetized cats (Reid et al., 1973; Van Spanning & Van Zweiten, 1973) but confirm the more recent study in anaesthetized rabbits (Hoefke & Warnke-Sachs, 1974) . The reason for these contrasting results may be the doses of clonidine used in the studies and it is possible that at higher doses a prejunctional action at a-adrenoreceptors may take place (Starke & Altmann, 1973) . This possibility is, however, not supported by the present results with intraventricular 6-hydroxydopamine in rats or in cats depleted of brain catecholamines by pretreatment with reserpine or n-methyl-p-tyrosine, in which the cardiovascular responses to clonidine were unchanged (Haeusler, 1974) .
The anti-hypertensive responses to clonidine were not modified by pretreatment with haloperidol, a central dopaminergic receptor antagonist, or by pretreatment with intraventricular 5,6-dihydroxytryptamine, which is known to deplete brain 5-hydroxytryptamine neurons (Baumgarten, Lachenmayer & Schlossberer, 1972) . Therefore the centrally induced cardiovascular responses to clonidine are unlikely to be mediated via central dopaminergic or serotonergic pathways.
The emetic action of clonidine and its analogue BAY 1470 was surprising since it seems to be unrelated to its a-adrenoreceptor-stimulating action. Also it appears not to be due to dopaminergic stimulation since it was observed after haloperidol pretreatment, which is known to antagonize apomorphine-induced vomiting (Janssen, Niemegeers & Schellekens, 1965) . Furthermore, since tolazoline, a close structural analogue of clonidine, and the injection of vehicle of the same pH did not induce any vomiting it would seem that the emetic action is not due to irritancy.
